GSK Fined Record $489M For Bribery In China
GlaxoSmithKline PLC was fined a record 3 billion yuan ($488.5 million) on Friday for bribing doctors in a verdict handed down by a Chinese court, which also sentenced several of the...To view the full article, register now.
Already a subscriber? Click here to view full article